Disala J. Fernando
GlaxoSmithKline R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study.
Journal: Annals of the rheumatic diseases
Published: December 18, 2023
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Journal: The Lancet. Infectious diseases
Published: October 31, 2022
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome.
Journal: Pulmonary pharmacology & therapeutics
Published: August 09, 2022
Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteers.
Journal: British journal of clinical pharmacology
Published: May 28, 2021
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Journal: British journal of clinical pharmacology
Published: April 30, 2021
Evaluation of Dynamic Contrast-Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study.
Journal: Journal of magnetic resonance imaging : JMRI
Published: November 12, 2020
Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor.
Journal: Pharmacology research & perspectives
Published: July 31, 2020
Association of the leptin receptor Q223R (rs1137101) polymorphism with obesity measures in Sri Lankans.
Journal: BMC research notes
Published: August 04, 2019
Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI.
Journal: EJNMMI research
Published: July 22, 2019
Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro-drug of miridesap.
Journal: British journal of pharmacology
Published: July 09, 2019
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase δ Inhibitor.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 14, 2019
Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: January 15, 2019
Last Updated: 09/26/2026